High-throughput combination assay for studying biofilm formation of uropathogenic Escherichia coli.


Journal

Archives of microbiology
ISSN: 1432-072X
Titre abrégé: Arch Microbiol
Pays: Germany
ID NLM: 0410427

Informations de publication

Date de publication:
05 Jul 2024
Historique:
received: 23 05 2024
accepted: 03 06 2024
revised: 23 05 2024
medline: 5 7 2024
pubmed: 5 7 2024
entrez: 5 7 2024
Statut: epublish

Résumé

Uropathogenic Escherichia coli, the most common cause for urinary tract infections, forms biofilm enhancing its antibiotic resistance. To assess the effects of compounds on biofilm formation of uropathogenic Escherichia coli UMN026 strain, a high-throughput combination assay using resazurin followed by crystal violet staining was optimized for 384-well microplate. Optimized assay parameters included, for example, resazurin and crystal violet concentrations, and incubation time for readouts. For the assay validation, quality parameters Z' factor, coefficient of variation, signal-to-noise, and signal-to-background were calculated. Microplate uniformity, signal variability, edge well effects, and fold shift were also assessed. Finally, a screening with known antibacterial compounds was conducted to evaluate the assay performance. The best conditions found were achieved by using 12 µg/mL resazurin for 150 min and 0.023% crystal violet. This assay was able to detect compounds displaying antibiofilm activity against UMN026 strain at sub-inhibitory concentrations, in terms of metabolic activity and/or biomass.

Identifiants

pubmed: 38967798
doi: 10.1007/s00203-024-04029-w
pii: 10.1007/s00203-024-04029-w
doi:

Substances chimiques

Xanthenes 0
resazurin 1FN9YD6968
Anti-Bacterial Agents 0
Gentian Violet J4Z741D6O5
Oxazines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344

Informations de copyright

© 2024. The Author(s).

Références

Abirami G, Durgadevi R, Velmurugan P, Ravi AV (2021) Gene expressing analysis indicates the role of Pyrogallol as a novel antibiofilm and antivirulence agent against Acinetobacter baumannii. Arch Microbiol 203(1):251–260. https://doi.org/10.1007/s00203-020-02026-3
doi: 10.1007/s00203-020-02026-3 pubmed: 32918098
Amador CI, Stannius RO, Røder HL, Burmølle M (2021) High-throughput screening alternative to crystal violet biofilm assay combining fluorescence quantification and imaging. J Microbiol Methods 190:106343. https://doi.org/10.1016/j.mimet.2021.106343
doi: 10.1016/j.mimet.2021.106343 pubmed: 34619138
Ankri S, Mirelman D (1999) Antimicrobial properties of allicin from garlic. Microbes Infect 1(2):125–129. https://doi.org/10.1016/S1286-4579(99)80003-3
doi: 10.1016/S1286-4579(99)80003-3 pubmed: 10594976
Bhandari S, Khadayat K, Poudel S, Shrestha S, Shrestha R, Devkota P, Khanal S, Marasini BP (2021) Phytochemical analysis of medicinal plants of Nepal and their antibacterial and antibiofilm activities against uropathogenic Escherichia coli. BMC Complement Med Ther 21(1):116. https://doi.org/10.1186/s12906-021-03293-3
doi: 10.1186/s12906-021-03293-3 pubmed: 33836728 pmcid: 8033659
Branda SS, Vik Å, Friedman L, Kolter R (2005) Biofilms: the matrix revisited. Trends Microbiol 13(1):20–26. https://doi.org/10.1016/j.tim.2004.11.006
doi: 10.1016/j.tim.2004.11.006 pubmed: 15639628
Brown MRW, Allison DG, Gilbert P (1988) Resistance of bacterial biofilms to antibiotics a growth-rate related effect? J Antimicrob Chemother 22(6):777–780 https://doi.org/10.1093/jac/22.6.777 .
doi: 10.1093/jac/22.6.777 pubmed: 3072331
Chang A, He Q, Li L, Yu X, Sun S, Zhu H (2021) Exploring the quorum sensing inhibition of isolated chrysin from Penicillium Chrysogenum DXY-1. Bioorg Chem 111:104894. https://doi.org/10.1016/j.bioorg.2021.104894
doi: 10.1016/j.bioorg.2021.104894 pubmed: 33865054
Delcaru C, Alexandru I, Podgoreanu P, Grosu M, Stavropoulos E, Chifiriuc MC, Lazar V (2016) Microbial biofilms in urinary tract infections and Prostatitis: etiology, pathogenicity, and combating strategies. Pathogens 5(4):65. https://doi.org/10.3390/pathogens5040065
doi: 10.3390/pathogens5040065 pubmed: 27916925 pmcid: 5198165
Dzobo K (2022) 2.20 - the role of Natural products as sources of therapeutic agents for innovative drug Discovery. In: Kenakin T (ed) Comprehensive Pharmacology. Elsevier, Oxford, pp 408–422. https://doi.org/10.1016/B978-0-12-820472-6.00041-4
doi: 10.1016/B978-0-12-820472-6.00041-4
Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW, Schmitz JE, Hadjifrangiskou M (2017) Biofilm formation by Uropathogenic Escherichia coli is favored under Oxygen conditions that mimic the bladder environment. Int J Mol Sci 18(10):2077. https://doi.org/10.3390/ijms18102077
doi: 10.3390/ijms18102077 pubmed: 28973965 pmcid: 5666759
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269–284. https://doi.org/10.1038/nrmicro3432
doi: 10.1038/nrmicro3432 pubmed: 25853778 pmcid: 4457377
Forsyth VS, Armbruster CE, Smith SN, Pirani A, Springman AC, Walters MS, Nielubowicz GR, Himpsl SD, Snitkin ES, Mobley HLT (2018) Rapid Growth of Uropathogenic Escherichia coli during human urinary tract infection. mBio 9(2). https://doi.org/10.1128/mbio.00186-18
Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49(2):53–70. https://doi.org/10.1067/mda.2003.7
doi: 10.1067/mda.2003.7 pubmed: 12601337
Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13(1):34–40. https://doi.org/10.1016/j.tim.2004.11.010
doi: 10.1016/j.tim.2004.11.010 pubmed: 15639630
Gilbert-Girard S, Savijoki K, Yli-Kauhaluoma J, Fallarero A (2020) Optimization of a high-throughput 384-Well plate-based screening platform with Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442 biofilms. Int J Mol Sci 21(9):3034. https://doi.org/10.3390/ijms21093034
doi: 10.3390/ijms21093034 pubmed: 32344836 pmcid: 7246797
Haindongo N, Anyogu A, Ekwebelem O, Anumudu C, Onyeaka H (2021) Antibacterial and antibiofilm effects of garlic (Allium sativum), ginger (Zingiber officinale) and mint (Mentha piperta) on Escherichia coli biofilms. Food Sci Appl Biotechnol 4(2):166–176. https://doi.org/10.30721/fsab2021.v4.i2.146
doi: 10.30721/fsab2021.v4.i2.146
He Z, Jiang W, Jiang Y, Dong J, Song Z, Xu J, Zhou W (2022) Anti-biofilm activities of coumarin as quorum sensing inhibitor for Porphyromonas gingivalis. J Oral Microbiol 14(1):2055523. https://doi.org/10.1080/20002297.2022.2055523
doi: 10.1080/20002297.2022.2055523 pubmed: 35368854 pmcid: 8967191
Husain FM, Perveen K, Qais FA, Ahmad I, Alfarhan AH, El-Sheikh MA (2021) Naringin inhibits the biofilms of metallo-β-lactamases (MβLs) producing Pseudomonas species isolated from camel meat. Saudi J Biol Sci 28(1):333–341. https://doi.org/10.1016/j.sjbs.2020.10.009
doi: 10.1016/j.sjbs.2020.10.009 pubmed: 33424314
Inglese J, Johnson RL, Simeonov A, Xia M, Zheng W, Austin CP, Auld DS (2007) High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 3(8):466–479. https://doi.org/10.1038/nchembio.2007.17
doi: 10.1038/nchembio.2007.17 pubmed: 17637779
Iversen PW, Eastwood BJ, Sittampalam GS, Cox KL (2006) A comparison of assay performance measures in screening assays: signal window, Z’ factor, and assay variability ratio. J BioMol Screen 11(3):247–252. https://doi.org/10.1177/1087057105285610
doi: 10.1177/1087057105285610 pubmed: 16490779
Iversen PW, Beck B, Chen Y-F, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, Iturria SJ, Montrose C, Moore RA, Weidner JR, Sittampalam GS (2012) HTS Assay Validation Assay Guidance Manual [Internet]. 01.10.2012 edn. Eli Lilly & Company and the National Center for Advancing Translational Sciences. https://www.ncbi.nlm.nih.gov/books/NBK83783/
Izano EA, Amarante MA, Kher WB, Kaplan JB (2008) Differential roles of Poly-N-Acetylglucosamine Surface Polysaccharide and Extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis Biofilms. Appl Environ Microbiol 74(2):470–476. https://doi.org/10.1128/AEM.02073-07
doi: 10.1128/AEM.02073-07 pubmed: 18039822
Jubair N, Fatima RM, Mahdi A, Abdullah YK NH (2022) Evaluation of catechin synergistic and antibacterial efficacy on biofilm formation and acrA gene expression of uropathogenic E. coli clinical isolates. Antibiotics. 11(9):1223. https://doi.org/10.3390/antibiotics11091223
Kang J, Li Q, Liu L, Jin W, Wang J, Sun Y (2018) The specific effect of gallic acid on Escherichia coli biofilm formation by regulating pgaABCD genes expression. Appl Microbiol Biotechnol 102(4):1837–1846. https://doi.org/10.1007/s00253-017-8709-3
doi: 10.1007/s00253-017-8709-3 pubmed: 29327068
Karygianni L, Ren Z, Koo H, Thurnheer T (2020) Biofilm Matrixome: Extracellular Components in Structured Microbial communities. Trends Microbiol 28(8):668–681. https://doi.org/10.1016/j.tim.2020.03.016
doi: 10.1016/j.tim.2020.03.016 pubmed: 32663461
Kot B (2019) Antibiotic resistance among Uropathogenic Escherichia coli. Pol J Microbiol 68(4):403–415. https://doi.org/10.33073/pjm-2019-048
doi: 10.33073/pjm-2019-048 pubmed: 31880885 pmcid: 7260639
Lee J-H, Park J-H, Cho HS, Joo SW, Cho MH, Lee J (2013) Anti-biofilm activities of quercetin and tannic acid against Staphylococcus aureus. Biofouling 29(5):491–499. https://doi.org/10.1080/08927014.2013.788692
Lescat M, Calteau A, Hoede C, Barbe V, Touchon M, Rocha E, Tenaillon O, Médigue C, Johnson JR, Denamur E (2009) A Module located at a chromosomal integration hot spot is responsible for the Multidrug Resistance of a reference strain from Escherichia coli Clonal Group A. Antimicrob Agents Chemother 53(6):2283–2288. https://doi.org/10.1128/aac.00123-09
doi: 10.1128/aac.00123-09 pubmed: 19364861 pmcid: 2687200
Lim JY, May JM, Cegelski L (2012) Dimethyl sulfoxide and ethanol elicit increased amyloid Biogenesis and amyloid-integrated biofilm formation in Escherichia coli. Appl Environ Microbiol 78(9):3369–3378. https://doi.org/10.1128/AEM.07743-11
doi: 10.1128/AEM.07743-11 pubmed: 22389366 pmcid: 3346451
Mittal S, Sharma M, Chaudhary U (2015) Biofilm and multidrug resistance in uropathogenic Escherichia coli. Pathogens Global Health 109(1):26–29. https://doi.org/10.1179/2047773215Y.0000000001
doi: 10.1179/2047773215Y.0000000001 pubmed: 25605466 pmcid: 4445292
Mukherjee S, Stamatis D, Li CT, Ovchinnikova G, Bertsch J, Sundaramurthi JC, Kandimalla M, Nicolopoulos PA, Favognano A, Chen IMA, Kyrpides NC, Reddy TBK (2023) Twenty-five years of genomes OnLine Database (GOLD): data updates and new features in v.9. Nucleic Acids Res 51(D1):D957–D963. https://doi.org/10.1093/nar/gkac974
doi: 10.1093/nar/gkac974 pubmed: 36318257
Neumann N, Honke M, Povydysh M, Guenther S, Schulze C (2022) Evaluating tannins and flavonoids from traditionally used Medicinal plants with biofilm inhibitory effects against MRGN E. coli. Molecules 27(7):2284. https://doi.org/10.3390/molecules27072284
doi: 10.3390/molecules27072284 pubmed: 35408683 pmcid: 9000218
Nickel JC, Ruseska I, Wright JB, Costerton JW (1985) Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 27(4):619–624. https://doi.org/10.1128/aac.27.4.619
doi: 10.1128/aac.27.4.619 pubmed: 3923925 pmcid: 180108
Paytubi S, de La Cruz M, Tormo JR, Martín J, González I, González-Menendez V, Genilloud O, Reyes F, Vicente F, Madrid C, Balsalobre C (2017) A high-throughput screening platform of Microbial Natural products for the Discovery of molecules with Antibiofilm Properties against Salmonella. Front Microbiol 8:326. https://doi.org/10.3389/fmicb.2017.00326
doi: 10.3389/fmicb.2017.00326 pubmed: 28303128 pmcid: 5332434
Peeters E, Nelis HJ, Coenye T (2008) Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 72(2):157–165. https://doi.org/10.1016/j.mimet.2007.11.010
doi: 10.1016/j.mimet.2007.11.010 pubmed: 18155789
Raeispour M, Ranjbar R (2018) Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control 7(1):118. https://doi.org/10.1186/s13756-018-0411-4
doi: 10.1186/s13756-018-0411-4 pubmed: 30305891 pmcid: 6171155
Reitzer L, Zimmern P (2019) Rapid Growth and Metabolism of Uropathogenic Escherichia coli in relation to urine composition. Clin Microbiol Rev 33(1). https://doi.org/10.1128/cmr.00101-19 . 10.1128/cmr.00101 – 19
Roe AJ, O’Byrne C, McLaggan D, Booth IR (2002) Inhibition of Escherichia coli growth by acetic acid: a problem with methionine biosynthesis and homocysteine toxicity. Microbiology 148(7):2215–2222. https://doi.org/10.1099/00221287-148-7-2215
doi: 10.1099/00221287-148-7-2215 pubmed: 12101308
Skogman ME, Vuorela PM, Fallarero A (2012) Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms. J Antibiot 65(9):453–459. https://doi.org/10.1038/ja.2012.49
doi: 10.1038/ja.2012.49
Summer K, Browne J, Hollanders M, Benkendorff K (2022) Out of control: the need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (DMSO). https://doi.org/10.1016/j.bioflm.2022.100081 . Biofilm 4:100081
Vikram A, Jayaprakasha GK, Jesudhasan PR, Pillai SD, Patil BS (2010) Suppression of bacterial cell–cell signalling, biofilm formation and type III secretion system by citrus flavonoids. J Appl Microbiol 109(2):515–527. https://doi.org/10.1111/j.1365-2672.2010.04677.x
doi: 10.1111/j.1365-2672.2010.04677.x pubmed: 20163489
Vysakh A, Midhun SJ, Jisha N, Jayesh K, Vijeesh V, Jyothis M, Latha MS (2020) Rotula aquatica Lour. Inhibits growth and biofilm formation of clinically isolated uropathogenic Escherichia coli. Asian Pac J Trop Biomed 10(12):547–554. https://doi.org/10.4103/2221-1691.297054
doi: 10.4103/2221-1691.297054
Zhang J-H, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J BioMol Screen 4(2):67–73. https://doi.org/10.1177/108705719900400206
doi: 10.1177/108705719900400206 pubmed: 10838414
Zhao F, Yang H, Bi D, Khaledi A, Qiao M (2020) A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections. Microb Pathog 144:104196. https://doi.org/10.1016/j.micpath.2020.104196
doi: 10.1016/j.micpath.2020.104196 pubmed: 32283258
Zhou J, Meng X, Han Q, Huang Y, Huo L, Lei Y (2022) An in vitro study on the degradation of multispecies biofilm of periodontitis-related microorganisms by bovine trypsin. Front Microbiol 13:951291. https://doi.org/10.3389/fmicb.2022.951291
doi: 10.3389/fmicb.2022.951291 pubmed: 35992661 pmcid: 9386051

Auteurs

M Li (M)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland.

C D Cruz (CD)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland.

P Ilina (P)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland.

P Tammela (P)

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki, FI-00014, Finland. paivi.tammela@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH